Study measures | Baseline | During treatment | 2Â months | 12-months |
---|---|---|---|---|
Demographic information (gender, age, etc.) | X | Â | Â | Â |
History of FMS (years of illness) | X | Â | Â | Â |
Contact details | X | Â | Â | Â |
SCID-I (depression module) | X | Â | Â | Â |
Screening measures | Â | Â | Â | Â |
 MMSE (cognitive impairment) | X |  |  |  |
Primary outcome measure | Â | Â | Â | Â |
 FIQR (functional impairment) | X |  | X | X |
Secondary outcome measures | Â | Â | Â | Â |
 FSDC (fibromyalginess) | X |  | X | X |
 HADS (anxiety and depression) | X |  | X | X |
 PSS-10 (perceived stress) | X |  | X | X |
 MISCI (subjective cognitive impairment) | X |  | X | X |
 EQ-5D-5L (quality of life) | X |  |  | X |
 CSRI (health economic evaluation) | X |  |  | X |
 FFMQa (mindfulness facets) | X |  | X | X |
 PCSa (pain catastrophizing) | X |  | X | X |
 PIPSa (psychological inflexibility) | X |  | X | X |
 SCS-12a (self-compassion) | X |  | X | X |
Other measures | Â | Â | Â | Â |
 Structural + Functional Neuroimaging data | X |  | X |  |
 Inflammatory data | X |  | X |  |
 CEQ (Expectation/Satisfaction with treatment) | X (EXP) |  | X (SAT) |  |
 PGIC & PSIC (Impression of change) |  |  | X | X |
 Treatment attendance form: Attendance at each scheduled MBSR/FibroQoL session |  | X |  |  |
 Log of MBSR and FibroQoL practices |  | X |  |  |
 Treatment fidelity (review of video-taped MBSR sessions) & monitoring of adverse events |  | X | X | X |